These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 19395589)

  • 21. Neural regulation of acetylcholinesterase-associated collagen Q in rat skeletal muscles.
    Trinkaus M; Pregelj P; Trkov S; Sketelj J
    J Neurochem; 2008 Jun; 105(6):2535-44. PubMed ID: 18373559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of in vivo genotoxic potential of fenofibrate in rats subjected to two-week repeated oral administration.
    Tawfeeq MM; Suzuki T; Shimamoto K; Hayashi H; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Aug; 85(8):1003-11. PubMed ID: 21127841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
    Jucker BM; Yang D; Casey WM; Olzinski AR; Williams C; Lenhard SC; Legos JJ; Hawk CT; Sarkar SK; Newsholme SJ
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1256-64. PubMed ID: 17726146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal muscle IGF-binding protein-3 and -5 expressions are age, muscle, and load dependent.
    Spangenburg EE; Abraha T; Childs TE; Pattison JS; Booth FW
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E340-50. PubMed ID: 12397024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of a Skeletal Muscle Injury and Drug Interactions in Lovastatin- and Fenofibrate-Coadministered Dogs.
    Kawata R; Yokoi T
    Int J Toxicol; 2019; 38(3):192-201. PubMed ID: 31113311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of Fenofibrate Markedly Elevates Fabp3 in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity.
    Kochansky CJ; Lyman MJ; Fauty SE; Vlasakova K; D'mello AP
    Lipids; 2018 Oct; 53(10):947-960. PubMed ID: 30592062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time and dose study on the response of rats to the hypolipidaemic drug fenofibrate.
    Price SC; Hinton RH; Mitchell FE; Hall DE; Grasso P; Blane GF; Bridges JW
    Toxicology; 1986 Oct; 41(2):169-91. PubMed ID: 3764941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of fat and muscle proteins in fenofibrate-fed type II diabetic OLETF rats: the fenofibrate-dependent expression of PEBP or C11orf59 protein.
    Hahm JR; Ahn JS; Noh HS; Baek SM; Ha JH; Jung TS; An YJ; Kim DK; Kim DR
    BMB Rep; 2010 May; 43(5):337-43. PubMed ID: 20510017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary excretion of oxidative metabolites of bilirubin in fenofibrate-treated rats.
    Kobayashi A; Takahashi T; Sugai S; Miyakawa Y; Iwatsuka H; Yamaguchi T
    J Toxicol Sci; 2003 May; 28(2):71-5. PubMed ID: 12820539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction for Goncalves et al., Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2146. PubMed ID: 29463704
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemorrhagic pancreatitis from fenofibrate and metformin toxicity: a case report.
    Lee MAB; Ng M; Yugendra P; Yao Y; Ponampalam R; Tan BKK
    World J Emerg Med; 2023; 14(6):495-498. PubMed ID: 37969214
    [No Abstract]   [Full Text] [Related]  

  • 32. Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle?
    El-Bassouny DR; Mansour AA; Ellakkany AS; Ayuob NN; AbdElfattah AA
    Histochem Cell Biol; 2023 Aug; 160(2):147-158. PubMed ID: 37270716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.
    Liu GZ; Hou TT; Yuan Y; Hang PZ; Zhao JJ; Sun L; Zhao GQ; Zhao J; Dong JM; Wang XB; Shi H; Liu YW; Zhou JH; Dong ZX; Liu Y; Zhan CC; Li Y; Li WM
    Br J Pharmacol; 2016 Mar; 173(6):1095-109. PubMed ID: 26787506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.
    Mahmoud AA; Elshazly SM
    PLoS One; 2014; 9(9):e106993. PubMed ID: 25202970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium.
    Greaves P; Chouinard L; Ernst H; Mecklenburg L; Pruimboom-Brees IM; Rinke M; Rittinghausen S; Thibault S; Von Erichsen J; Yoshida T
    J Toxicol Pathol; 2013; 26(3 Suppl):1S-26S. PubMed ID: 25035576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenofibrate-induced muscular toxicity is associated with a metabolic shift limited to type-1 muscles in rats.
    Okada M; Sano F; Ikeda I; Sugimoto J; Takagi S; Sakai H; Yanai T
    Toxicol Pathol; 2009 Jun; 37(4):517-20. PubMed ID: 19395589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal muscle susceptibility to clofibrate induction of lesions in rats.
    Okada M; Inoue Y; Ube M; Sano F; Ikeda I; Sugimoto J; Takagi S
    Toxicol Pathol; 2007 Jun; 35(4):517-20. PubMed ID: 17562484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats.
    Ohta T; Masutomi N; Tsutsui N; Sakairi T; Mitchell M; Milburn MV; Ryals JA; Beebe KD; Guo L
    Toxicol Pathol; 2009 Jun; 37(4):521-35. PubMed ID: 19458390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity.
    Seachrist JL; Loi CM; Evans MG; Criswell KA; Rothwell CE
    Toxicol Sci; 2005 Dec; 88(2):551-61. PubMed ID: 16141437
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.